SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Stride, Inc. (LRN) trades at a trailing P/E of 12.1, forward P/E of 13.2. Trailing earnings yield is 8.24%, forward earnings yield 7.60%. PEG 0.45 (Peter Lynch undervalued ≤1.0). Graham Number is $77.37.
Criteria proven by this page:
- VALUE (66/100, Pass) — P/E is below market average (12.1); PEG ≤ 1.0 — Peter Lynch undervalued (0.45); analyst target implies upside (+17.1%); earnings yield beats bond yields (8.24%).
- PEG Ratio 0.45 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 8.24% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $109.50 (+17.1% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 74/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
66/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — LRN
Valuation Multiples
P/E (TTM)12.1
Forward P/E13.2
PEG Ratio0.45
Forward PEG0.67
P/B Ratio2.50
P/S Ratio1.56
EV/EBITDA7.3
Per Share Data
EPS (TTM)$7.40
Forward EPS (Est.)$7.11
Book Value / Share$35.93
Revenue / Share$58.48
FCF / Share$4.87
Yields & Fair Value
Earnings Yield8.24%
Forward Earnings Yield7.60%
Dividend Yield0.00%
Graham Number$77.37
SharesGrow IV$154.13 (+64.8%)
Analyst Target$109.50 (+17.1%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
52.0 |
-3.02 |
0.84 |
0.54 |
- |
| 2017 |
1,521.8 |
-15.88 |
1.19 |
0.77 |
- |
| 2018 |
23.3 |
0.00 |
1.10 |
0.70 |
- |
| 2019 |
31.3 |
0.84 |
1.84 |
1.15 |
- |
| 2020 |
43.9 |
-1.24 |
1.59 |
1.03 |
- |
| 2021 |
18.1 |
0.10 |
1.61 |
0.84 |
- |
| 2022 |
15.8 |
0.35 |
2.08 |
1.00 |
- |
| 2023 |
12.4 |
0.76 |
1.66 |
0.86 |
- |
| 2024 |
14.4 |
0.24 |
2.50 |
1.44 |
- |
| 2025 |
21.7 |
0.55 |
4.22 |
2.60 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.23 |
$872.7M |
$9.04M |
1% |
| 2017 |
$0.01 |
$888.52M |
$451K |
0.1% |
| 2018 |
$0.68 |
$917.73M |
$27.62M |
3% |
| 2019 |
$0.91 |
$1.02B |
$37.21M |
3.7% |
| 2020 |
$0.60 |
$1.04B |
$24.51M |
2.4% |
| 2021 |
$1.71 |
$1.54B |
$71.45M |
4.6% |
| 2022 |
$2.52 |
$1.69B |
$107.13M |
6.4% |
| 2023 |
$2.97 |
$1.84B |
$126.87M |
6.9% |
| 2024 |
$4.69 |
$2.04B |
$204.18M |
10% |
| 2025 |
$5.95 |
$2.41B |
$287.94M |
12% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$7.11 |
$7.10 – $7.12 |
$2.52B |
$2.52B – $2.53B |
2 |
| 2027 |
$7.82 |
$7.81 – $7.84 |
$2.64B |
$2.64B – $2.65B |
2 |
| 2028 |
$8.36 |
$8.35 – $8.38 |
$2.8B |
$2.8B – $2.8B |
1 |
| 2029 |
$9.03 |
$9.02 – $9.06 |
$2.99B |
$2.99B – $3B |
1 |
| 2030 |
$9.66 |
$9.65 – $9.69 |
$3.13B |
$3.12B – $3.13B |
1 |
